In the mouse product, offering genetic validation of CRK12:CYC9 as a novel drug goal for trypanosomiasis. Further more, practical characterisation of CRK12 and CYC9 applying RNA interference reveals roles for these proteins in endocytosis and cytokinesis, respectively. Protection and efficacy of concentrating on platelet proteinase-activated receptors together with current anti-platelet https://julieg899jxl5.westexwiki.com/user